Literature DB >> 10599308

Significance of the small subtelomeric area of chromosome 1 (1p36.3) in the progression of malignant melanoma: FISH deletion screening with YAC DNA probes.

M Poetsch1, C Woenckhaus, T Dittberner, M Pambor, G Lorenz, F H Herrmann.   

Abstract

The short arm of chromosome 1 (1p), especially the subtelomeric region of 1p36, is a common site for abnormalities in malignant melanoma of the skin. In a recent study nodular melanomas displayed deletions of 1p36 in an augmented percentage of cases. To evaluate the dimension of these deletions and to study their significance for the progression of malignant melanoma we analyzed seven melanoma cell lines, 32 primary tumors, and 32 metastatic tumors by fluorescence in situ hybridization with the DNA probe D1Z2 in 1p36.3 and eight YAC DNA probes hybridizing to 1p36, 1p32, 1p31, and 1p21. All cell lines, 91% of the metastatic tumors and 63% of nodular melanomas showed a deletion of 1p36.3. In the YAC hybridization experiments, the most frequent deletions were found in 1p36 in all cell lines, in 13% of nodular melanoma, and in 44% of metastatic tumors. Deletions in 1p36 were mostly confined to a rather small area near the locus D1Z2. The frequent occurrence of this deletion in melanomas with a high metastatic potential and the abundant accumulation of this deletion in metastasis point to genes located on 1p36, which might be of significance for the metastatic capability of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599308     DOI: 10.1007/s004280050406

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

1.  Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.

Authors:  W Xu; S Zhu; Y Zhou; Y Jin; H Dai; X Wang
Journal:  Cancer Gene Ther       Date:  2015-10-09       Impact factor: 5.987

2.  Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.

Authors:  Nicole M A White; Daniel W Newsted; Olena Masui; Alexander D Romaschin; K W Michael Siu; George M Yousef
Journal:  Tumour Biol       Date:  2013-10-19

3.  Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.

Authors:  Yu-Wen Zhang; Ben Staal; Karl J Dykema; Kyle A Furge; George F Vande Woude
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.